The impact of COVID-19 on global health systems and business markets has been profound in scale and impact. The United Nations predicted that the pandemic will result in a $1 trillion hit to the world economy this year alone. Given the massive scale of disruption, governments and pharmaceutical companies have rallied together in the race to develop urgently needed vaccines and treatments, whilst large corporations and SMEs worldwide have had to pivot their business models and deploy innovative solutions to survive significant economic challenges. In the current climate, how then might IP offices and organisations (IPOs) contribute to the conversation and continue to be crucial anchors of innovation? In this exclusive webinar, hear directly from the Heads of IP offices and organisations as they examine the impact of COVID-19 on the IP industry and discuss how IPOs can leverage data, expertise and international networks to ably support creators and innovators seeking to cope with the longer-term impact of a pandemic.